Stephen Mandel
Lone Pine Capital
Stephen Mandel DaVita HealthCare Partners Inc stake
total: 304
Lone Pine Capital DVA trades
- Total transactions:
- 8
- New positions:
- 2
- Sold out:
- 2
- Added:
- 3
- Reduced:
- 1
- Held since:
- 2014 Q4
- Held for:
- 4 quarters
- Latest activity:
- 2015 Q4
According to 2026 Q2 report, Stephen Mandel doesn't hold any DaVita HealthCare Partners Inc (DVA) shares. To date, the estimated cost basis is nearly $75.74 for "buy" trades and estimated average "sell" price is $72.33. Lone Pine Capital first purchased DVA in 2013 Q3, initially acquiring about 6.30M shares. Stephen Mandel later completely sold out the position and invested in DaVita HealthCare Partners Inc again in 2014 Q4. Since the initial investment in DaVita HealthCare Partners Inc (DVA), Lone Pine Capital has made 7 more transactions.
When did Stephen Mandel sell DaVita HealthCare Partners Inc (DVA)?
Stephen Mandel sold off the entire DaVita HealthCare Partners Inc (DVA) position in 2015 Q4.
When did Stephen Mandel buy DaVita HealthCare Partners Inc (DVA)?
Stephen Mandel first invested in DaVita HealthCare Partners Inc (DVA) in 2013 Q3 at the reported quarter-end price of $56.90 per share.
What's the cost basis of Lone Pine Capital's DVA stake?
The estimated cost basis for DaVita HealthCare Partners Inc (DVA) stake is around $75.74 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $75.74
- Weighted AVG sell price:
- $72.33
Stephen Mandel's historical trades in DaVita HealthCare Partners Inc
8 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2015 Q4
|
0.00%
|
$72.33
|
-100% (-7,918,998)
|
|||
|
2015 Q3
|
2.56%
|
$72.33
|
+45.15% (+2,463,224)
|
|||
|
2015 Q1
|
1.89%
|
$81.28
|
+38.47% (+1,515,605)
|
|||
|
2014 Q4
|
1.28%
|
$75.74
|
new
|
|||
|
2014 Q2
|
0.00%
|
$68.85
|
-100% (-3,655,739)
|
|||
|
2014 Q1
|
1.13%
|
$68.85
|
-56.84% (-4,815,038)
|
|||
|
2013 Q4
|
2.46%
|
$63.37
|
+34.41% (+2,168,750)
|
|||
|
2013 Q3
|
1.68%
|
$56.90
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.